Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy (CONSIGN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01538680

Expanded Access Status : No longer available

First Posted : February 24, 2012

Last Update Posted : March 26, 2018

Sponsor:

Information provided by (Responsible Party):

Bayer

Study Details
Tabular View
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Expanded Access Status :	No longer available
Primary Completion Date :	No date given
Study Completion Date :	No date given

To Top